Antiviral assays test the ability of substances, including nanoparticles, to inhibit the replication of viruses. These assays are essential for evaluating the efficacy of potential antiviral agents, helping researchers understand how nanoparticles can combat viral infections. Delving into these assays allows for the ultimate development of new antiviral therapies and enhances strategies for disease prevention and treatment.